Menquadfi 10 µg, 55 µg Solution for injection
PDF Leaflet Revision Date: 19 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunisation against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y.
Dosage (summary)
One single dose (0.5 mL) for individuals 12 months and older.
Special Populations
- Immunocompromised
- Elderly
Pregnancy & Breastfeeding
Use in pregnancy only if benefits outweigh risks; unknown if excreted in breast milk.
Key Drug Interactions
- Co-administer with separate syringes
- May affect immune response in immunosuppressive therapy
Contraindications
- Hypersensitivity to active substances or excipients
- Previous adverse reaction to similar vaccines
Common side effects
- Injection site pain
- Myalgia
- Fever
- Irritability
Counselling Points
- Monitor for allergic reactions post-vaccination
- Record vaccine name and batch number for traceability
Serious warnings
- Risk of anaphylaxis
- Do not administer subcutaneously or intravascularly
Important Disclaimer
The Menquadfi 10 µg, 55 µg Solution for injection professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
